At the news
? NEUTRALIMPACT 5/10 CLUSTER filed Jun 30, 2026 at 19:05 ET
Three Dyne Therapeutics insiders sold a combined $5.02M in shares over a 6-day window, led by Director Rhodes ($4.9M). CFO Lucera sold a small amount ($48K). The sales follow a recent $50M borrowing under an expanded $400M Hercules debt facility (8-K on 6/17). Total selling represents ~0.14% of market cap, a modest amount that is not alarming given the pre-revenue biotech context.
- Insider cluster: 3 insiders sold 5 trades totaling $5.02M from June 23-29.
- Director Jason Rhodes sold $5.0M (bulk of sales); CFO Erick Lucera sold $48K.
- Sales follow June 17 debt facility expansion ($50M draw, $400M total capacity).
- Total sales represent ~0.14% of DYN's $3.5B market cap.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access